56P Efficacy and safety of nivolumab (Nivo) in recurrent and/or metastatic platinum-refractory squamous cell carcinoma of head and neck (R/M SCCHN): A real-world data study

J.J Soto Castillo,J Esteban Villarrubia,P Alvarez Ballesteros,P Garrido Lopez,A Soria Rivas

doi:10.1016/j.annonc.2020.10.543

56P Efficacy and safety of nivolumab (Nivo) in recurrent and/or metastatic platinum-refractory squamous cell carcinoma of head and neck (R/M SCCHN): A real-world data study

J.J Soto Castillo, J Esteban Villarrubia + Show 3 more

Open Access

https://doi.org/10.1016/j.annonc.2020.10.543

Copy DOI

Journal: Annals of oncology : official journal of the European Society for Medical Oncology	Publication Date: Dec 1, 2020
Citations: 1	License type: publisher-specific-oa

Affiliation: Hospital Universitario Ramón y Cajal

#Real-world Data Study #Safety Of Nivolumab + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

56P Efficacy and safety of nivolumab (Nivo) in recurrent and/or metastatic platinum-refractory squamous cell carcinoma of head and neck (R/M SCCHN): A real-world data study

Full Text